Research Topics
| Marc ArbynSummaryAffiliation: Scientific Institute of Public Health Country: Belgium Publications
| Collaborators
|
Detail Information
Publications
Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasiaMarc Arbyn
European Network for Cervical Cancer Screening and Unit for Evaluation of Cancer Screening Programmes, Scientific Institute of Public Health, Brussels, Belgium
J Natl Cancer Inst 96:280-93. 2004..We performed a meta-analysis to assess the accuracy of human papillomavirus (HPV) DNA testing as an alternative to repeat cytology in women who had equivocal results on a previous Pap smear...
The challenges of organising cervical screening programmes in the 15 old member states of the European UnionMarc Arbyn
Unit of Cancer Epidemiology and Belgian Cancer Centre, Scientific Institute of Public Health, Brussels, Belgium
Eur J Cancer 45:2671-8. 2009....
Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer ScreeningMarc Arbyn
Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
J Clin Virol 38:189-97. 2007..The purpose of the appendix on vaccination is to present current knowledge. Developing guidelines for future use of HPV vaccines in Europe, is the object of a new grant offered by the European Commission...
Trends of cervical cancer mortality in the member states of the European UnionMarc Arbyn
Belgian Cancer Centre, Scientific Institute of Public Health, Brussels, Belgium
Eur J Cancer 45:2640-8. 2009..In the current paper, we analyse cervical cancer mortality trends in the 27 member states since 1970 and, subsequently, try to explain how screening and other factors have driven changes...
How to evaluate emerging technologies in cervical cancer screening?Marc Arbyn
Unit of Cancer Epidemiology Belgian Cancer Centre, Scientific Institute of Public Health, Brussels, Belgium
Int J Cancer 125:2489-96. 2009..The 5-phases framework should guide researchers and test developers in planning assessment of new biomarkers and protect clinicians and stakeholders against premature claims for insufficiently evaluated products...
Analysis of 13 million individual patient records pertaining to Pap smears, colposcopies, biopsies and surgery on the uterine cervix (Belgium, 1996-2000)Marc Arbyn
Belgian Cancer Center Unit of Cancer Epidemiology, Scientific Institute of Public Health, J Wytsman Street 14, Brussels, Belgium
Prev Med 48:438-43. 2009..Cervical cancer screening by surveys overestimate coverage because of selection and reporting biases...
Liquid compared with conventional cervical cytology: a systematic review and meta-analysisMarc Arbyn
Scientific Institute of Public Health, Brussels, Belgium
Obstet Gynecol 111:167-77. 2008..To compare test performance characteristics of conventional Pap tests and liquid-based cervical cytology samples...
Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and IndiaMarc Arbyn
Scientific Institute of Public Health, Unit of Cancer Epidemiology, Brussels, Belgium
Int J Cancer 123:153-60. 2008..Gold standard verification error could also explain the surprisingly low sensitivity of HC2, which contrasts with findings from other studies...
Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in BelgiumMarc Arbyn
Unit of Cancer Epidemiology, Scientific Institute of Public Health, J Wytsmanstreet 14, BE 1050 Brussels, Belgium
Cancer Epidemiol Biomarkers Prev 18:321-30. 2009....
International agreement to join forces in synthesizing evidence on new methods for cervical cancer preventionMarc Arbyn
Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
Cancer Lett 278:1-2. 2009....
Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysisM Arbyn
Scientific Institute of Public Health, Brussels, Belgium
BMJ 337:a1284. 2008..To assess the relative risk of perinatal mortality, severe preterm delivery, and low birth weight associated with previous treatment for precursors of cervical cancer...
Cervical cytology biobanks as a resource for molecular epidemiologyMarc Arbyn
Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
Methods Mol Biol 675:279-98. 2011..To understand the limitations of CCB, more studies are needed on quality of samples in relation to sample type, storage procedures, and duration of storage...
Trends in cervical cancer incidence and mortality in the Baltic countries, Bulgaria and RomaniaMarc Arbyn
Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
Int J Cancer 128:1899-907. 2011..Rising trends of cervical cancer in the most affected EU member states reveal a worrying pattern that warrants urgent preventive actions...
Cervical cytology biobanking in EuropeMarc Arbyn
Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
Int J Biol Markers 25:117-25. 2010..To understand the limitations of CCB, more studies are needed on the quality of samples in relation to sample type, storage procedures, and duration of storage...
Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rateMarc Arbyn
Scientific Institute of Public Health, Brussels, Belgium
J Cell Mol Med 13:648-59. 2009..Research is needed to identify more specific methods to triage women with low-grade squamous cervical lesions...
The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracyMarc Arbyn
Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
Int J Cancer 132:101-8. 2013..35; 95% CI = 1.11-1.66). Results were similar for detection of CIN2 or worse. In both triage of ASC-US and LSIL, APTIMA is as sensitive but more specific than HC2 for detecting cervical precancer...
p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysisJolien Roelens
Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
Cancer Cytopathol 120:294-307. 2012..74 [95% CI, 1.99-3.76]). The published literature indicated the improved accuracy of p16(INK4a) compared with HC2 testing in the triage of women with ASC-US. In LSIL triage, p16(INK4a) was more specific but less sensitive...
Chapter 9: Clinical applications of HPV testing: a summary of meta-analysesMarc Arbyn
Unit of Cancer Epidemiology, Scientific Institute of Public Health, J Wytsmanstreet 14, Brussels, Belgium
Vaccine 24:S3/78-89. 2006..More than ever, clinicians need regularly updated reviews given the continuously increasing amount of new information regarding innovative cervical cancer prevention methods...
Evidence regarding human papillomavirus testing in secondary prevention of cervical cancerMarc Arbyn
Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
Vaccine 30:F88-99. 2012..This article forms part of a special supplement entitled "Comprehensive Control of HPV Infections and Related Diseases" Vaccine Volume 30, Supplement 5, 2012...
EUROGIN 2011 roadmap on prevention and treatment of HPV-related diseaseMarc Arbyn
Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
Int J Cancer 131:1969-82. 2012....
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesionsMarc Arbyn
Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
Cochrane Database Syst Rev 3:CD008054. 2013..This review evaluates two ways to triage women with ASCUS or LSIL: repeating the cytological test, and DNA testing for high-risk types of the human papillomavirus (hrHPV) - the main causal factor of cervical cancer...
Belgian Parliament calls for organised cervical cancer screening and HPV research throughout EuropeMarc Arbyn
European Network of Cervical Cancer Screening, Scientific Institute of Public Health, Brussels, Belgium
Lancet Oncol 3:74. 2002
Trends in cervical cancer incidence and mortality in Bulgaria, Estonia, Latvia, Lithuania and RomaniaMarc Arbyn
Unit of Cancer Epidemiology Scientific Institute of Public Health, Brussels, Belgium
Tumori 96:517-23. 2010..The burden of cervical cancer varies considerably in the European Union. In this paper, we describe trends in incidence of and mortality from this cancer in the five most affected member states...
Cytological screening for cervical cancer in the province of Limburg, BelgiumMarc Arbyn
Unit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
Eur J Cancer Prev 20:18-24. 2011..Obligatory registration, use of a uniform terminology and linkage with population and follow-up data are needed to give a cytology registry its full role in an organized screening programme...
European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytologyM Arbyn
Scientific Institute of Public Health, Brussels, Belgium, and European Cancer Network, IARC, Lyon, France
Cytopathology 18:133-9. 2007..Subsequently, the slide or vial and the completed request form are sent to the laboratory for cytological interpretation...
Burden of cervical cancer in Europe: estimates for 2004M Arbyn
Scientific Institute of Public Health, Brussels, Belgium
Ann Oncol 18:1708-15. 2007..The European Commission should maintain cervical cancer control in future action plans and increase support to the most affected member states...
Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidenceM Arbyn
Scientific Institute of Public Health, Brussels, Belgium
Gynecol Oncol 99:S7-11. 2005..By triage, those women can be identified who need referral for diagnostic exploration with colposcopy and/or biopsy...
Metaanalysis of the accuracy of rapid prescreening relative to full screening of pap smearsMarc Arbyn
Scientific Institute of Public Health, Brussels, Belgium
Cancer 99:9-16. 2003..In a previous study, we pooled data on the diagnostic quality of rapid reviewing (RR) of cervical smears initially reported as normal or unsatisfactory. We now focus on rapid prescreening (RPS) of unreported smears...
The burden of cervical cancer in south-east Europe at the beginning of the 21st centuryMarc Arbyn
Scientific Institute of Public Health, Unit of Cancer Epidemiology, Brussels, Belgium
Coll Antropol 31:7-10. 2007..Thus, appropriate cervical cancer prevention programmes should be set up without delay in this part of Europe...
European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary documentM Arbyn
Unit of Cancer Epidemiology Belgian Cancer Center, Scientific Institute of Public Health, Brussels, Belgium
Ann Oncol 21:448-58. 2010....
Impact of genetic notification on smoking cessation: systematic review and pooled-analysisSylviane de Viron
Operational Direction Public Health and Surveillance, Scientific Institute of Public Health, Brussels, Belgium
PLoS ONE 7:e40230. 2012..Secondary objectives were to assess the impact of genetic notification on intention-to-quit smoking and on emotional outcomes as well as the understanding and the recall of this notification...
Trend of cervical cancer mortality in Belgium (1954-1994): tentative solution for the certification problem of unspecified uterine cancerMarc Arbyn
Department of Epidemiology, Scientific Institute of Public Health, Brussels, Belgium
Int J Cancer 102:649-54. 2002..The tendency of increasing mortality in women born after 1935 required particular attention. Nevertheless, the slope of the corrected recent cohort effect remained limited in Belgium, probably as a consequence of screening...
Cervical cancer screening in BelgiumM Arbyn
Scientific Institute of Public Health, J Wytsmanstreet 14, B 1050, Belgium
Eur J Cancer 36:2191-7. 2000..The coverage is lower in the Walloon and the Capital Region. Rationalisation of the policy regarding cancer screening involving all concerned authorities of the country is necessary...
Monitoring of human papillomavirus vaccinationJ Dillner
WHO HPV LabNet Global Reference Laboratory at Department of Clinical Microbiology, University Hospital, Malmo
Clin Exp Immunol 163:17-25. 2011..Internationally standardized monitoring and evaluation of prophylactic HPV vaccination programmes will be essential for arriving at the most cost-effective strategies for cancer control...
The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literatureEvangelos Paraskevaidis
Department of Obstetrics and Gynecology, University Hospital of Ioannina, Greece
Cancer Treat Rev 30:205-11. 2004..Cytology and colposcopy may still be needed in order to rule out false positive and false negative results...
Re: Have we resolved how to triage equivocal cervical cytology?Marc Arbyn
J Natl Cancer Inst 96:1401-2; author reply 1402. 2004
Parliament calls for organised cervical cancer screening and HPV researchMarc Arbyn
Eur J Obstet Gynecol Reprod Biol 101:101-2. 2002
Immunocytochemistry in liquid-based cervical cytology: analysis of clinical use following a cross-sectional studyShaira Sahebali
Department of Pathology, University of Antwerp, Groenenborgerlaan 171, BE 2020 Antwerp, Belgium
Int J Cancer 118:1254-60. 2006..However, clear methodological standards are needed for optimal performance of immunocytochemistry in a clinical setting...
A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screeningPhilip Davies
European Cervical Cancer Association, 68 cours Albert Thomas, Lyon, France
Int J Cancer 118:791-6. 2006..Our study reviews the randomized controlled trials that are currently being conducted in Europe to establish the performance of HPV testing as a primary cervical cancer screening test...
Visual inspection with acetic acid as a cervical cancer test: accuracy validated using latent class analysisLynne Gaffikin
Cervical Cancer Prevention Program, JHPIEGO, Baltimore, USA
BMC Med Res Methodol 7:36. 2007..The data were originally collected at peri-urban health clinics in Zimbabwe...
Human papillomavirus testing with conventional Pap smear screening in three inner London community clinicsAmanda Herbert
Histopathology Department, St Thomas Hospital, London, UK
J Fam Plann Reprod Health Care 33:171-6. 2007..Outcome at colposcopy was compared with the records of 1871 women aged 20-49 years attending colposcopy during the same period of time (routine colposcopies)...
European Union support for a Turkish reproductive health project to assess alternative cervical cancer screening methods in Sanliurfa (rural south-east Turkey)Marc Arbyn
Eur J Cancer Prev 15:552-3. 2006
Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studiesGeorge Koliopoulos
Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford, UK
Gynecol Oncol 104:232-46. 2007..This is a meta-analysis of studies comparing HPV testing to cytology with regard to their accuracy in the detection of underlying high grade cervical intraepithelial neoplasia in primary cervical cancer screening...
Improving the quality of communication in organised cervical cancer screening programmesLivia Giordano
CPO Piemonte, Torino, Italy
Patient Educ Couns 72:130-6. 2008..To provide health professionals involved in cervical cancer screening with an insight into the complex issues relating to communication about screening and to provide a framework for a more effective communication strategy...
European Commission's proposal for a council recommendation on cancer screeningMarc Arbyn
BMJ 327:289-90. 2003
Effects of quadrivalent human papillomavirus vaccinationMarc Arbyn
Lancet 370:1031-2; author reply 1032-3. 2007
Incidence of vaginal intraepithelial neoplasia after hysterectomy for cervical intraepithelial neoplasia: a retrospective studySilke Schockaert
Department of Obstetrics and Gynecology, University Hospital Gasthuisberg, Catholic University Leuven, Leuven, Belgium
Am J Obstet Gynecol 199:113.e1-5. 2008..Hysterectomy with concomitant cervical intraepithelial neoplasia (CIN), is often considered a definitive treatment for CIN, but development of subsequent vaginal intraepithelial neoplasia (VAIN) is known to range from 0.9% to 6.8%...
Report on the 2007 International Workshop on Human Papillomaviruses and Consensus Recommendations for Cervical Cancer PreventionMagdalena Grce
Division of Molecular Medicine, Ruder Boskovic Institute, Department of Molecular Medicine, Zagreb, Croatia
Cent Eur J Public Health 16:38-40. 2008....
